Precision medicine
The funding round brings the company's total raise to $1.86 billion since it launched in 2018.
The projects will make use of genome sequencing data for more personalized, preventative and cost-effective healthcare.
Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.
The aim of the partnership is to research how AI can help predict cancer progression.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.
Around two in five Malaysians are said to have metabolic syndrome.
Also, Indian diagnostics chain Redcliffe Labs has rolled out a mobile diabetes risk calculation feature.
They will collaborate on identifying novel therapeutic drug candidates for lung cancer.
The tech aims to deliver AI-driven drug response prediction to human oncology.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.